Navigation Links
Novartis Study Shows QTI571 Significantly Improved Walking Distance in Patients with Life-Threatening Pulmonary Arterial Hypertension
Date:9/25/2011

ributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

About Novartis

Novartis Pharmaceuticals Corporation researches, develops, manufactures and markets innovative prescription drugs used to treat a number of diseases and conditions, including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease and respiratory. The company's mission is to improve people's lives by pioneering novel healthcare solutions.

Located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG, which provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, consumer health products, preventive vaccines and diagnostic tools. Novartis is the only company with leading positions in these areas. In 2010, the Group's continuing operations achieved net sales of USD 50.6 billion, while approximately USD 9.1 billion (USD 8.1 billion excluding impairment and amortization charges) was invested in R&D throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 121,000 full-time-equivalent as
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
3. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
4. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
5. More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
6. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
7. Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
8. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
9. Results In The New England Journal Of Medicine Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
10. Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
11. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... 26, 2015 Research and Markets ... the "Computer Aided Detection (CAD) - Global ... Annual estimates and forecasts are provided ... six-year historic analysis is provided for these markets. ... and secondary research. Company profiles are primarily based ...
(Date:3/30/2015)... March 30, 2015  Building on the momentum of the ... provider of medical alert systems, has announced aggressive plans to ... program and Managed Care business models. The first ... , Tennessee and Louisiana ... regional contracts to span statewide coverage in each state. This ...
(Date:3/30/2015)...  Rigrodsky & Long, P.A.: , Do you ... )? , Did you purchase any of your shares ... the proposed buyout price is too low? , Do ... Rigrodsky & Long, P.A. announces that it is investigating ... Pharmaceuticals, Inc. ("Auspex" or the "Company") (NASDAQ GM: ASPX ...
Breaking Medicine Technology:Computer Aided Detection (CAD) - Global Strategic Business Report 2015-2020: Rising Incidence of Cancer - A Major Market Driver 2Computer Aided Detection (CAD) - Global Strategic Business Report 2015-2020: Rising Incidence of Cancer - A Major Market Driver 3Computer Aided Detection (CAD) - Global Strategic Business Report 2015-2020: Rising Incidence of Cancer - A Major Market Driver 4MedScope's Aggressive 2015 Expansion Focuses on Medicaid Waiver and Managed Care Organizations 2AUSPEX PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 2
(Date:3/30/2015)... March 30, 2015 Wright & Schulte ... lawsuits, notes that the number of Syngenta corn ... underway in U.S. District Court, District of Kansas, have ... 2014. "According to an update released by the U.S. ... at least 493 Syngenta lawsuits are now consolidated in ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 A new ... in California Superior Court on behalf of a child ... defect after his mother was prescribed the anti-nausea medication ... March 6th filing in Alameda Superior Court, the baby’s ... vomiting that she experienced in the early months of ...
(Date:3/30/2015)... Los Angeles, CA (PRWEB) March 30, 2015 ... “6 New Ways to Blast Away Fat,” details six new ... these treatments require injections and one is a topical product. ... ( UltraShape and Liposonix ) or freezing cold ... “There are so many options now available to us to ...
(Date:3/30/2015)... 2015 In a recent report published ... Chris Christie is championing effective drug and alcohol treatment ... scrambling to recover funds to stabilize the addiction treatment ... victims of drug and alcohol addiction. Harbor Village Detox ... by substance use disorders in New Jersey, in hopes ...
(Date:3/30/2015)... 2015 This report studies the ... the forecast period of 2014 to 2019. This ... of 6.5% from 2014 to 2019. , Further ... report, the global pharmacovigilance and drug safety software ... the basis of functionality, namely, adverse event reporting ...
Breaking Medicine News(10 mins):Health News:Syngenta Corn Lawsuit Claims Continue To Be Filed By Non GMO Corn Farmers Reports Wright & Schulte LLC 2Health News:Syngenta Corn Lawsuit Claims Continue To Be Filed By Non GMO Corn Farmers Reports Wright & Schulte LLC 3Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 2Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 3Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 4Health News:UltraShape and CoolSculpting: Two New Fat-Busting Technologies 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 3Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 2Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 3Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 4
... Brain Institute (QBI) have now found a process that ... from dementia and acquired brain injury. ,The research ... associated with memory function and where the brain's ability ... with age. ,The study by Dr Natalie Bull ...
... conducted by researchers at University of Texas Southwestern Medical ... problem //faced by diabetics by increasing their blood pressure. ... professor and chief of the division of nutrition and ... a high-carb diet on blood pressure with a diet ...
... Germany’s drugs firm Grunenthal has developed a new drinking ... bitter medicine// to their children. The straw contains and ... neutral taste. The straw also contains a filter which ... been taken. ,The tasteless cover of the granulated ...
... Harming Themselves To Get Relief From Frustrations. ,UK based ... the country inflict injuries upon themselves due to feelings ... upon themselves has been contemplated by 20% of the ... have actually harmed themselves. ,The Priory survey ...
... implicated as a causative factor in many different forms of ... cancer and respiratory diseases // . For example, 1/3rd of ... are being taken by members of the scientific community to ... and to help curb the same. ,A new ...
... claim that the weight gained during the holiday season is ... ,The weight gain starts from the Thanksgiving weekend ... battle of the holiday bulge., ,To stop this bulge ... have more fruits and non-fat yogurt, drink skimmed milk, drink ...
Cached Medicine News:Health News:Research Targets treatment for dementia and brain injuries 2Health News:Carbohydrate-rich Diet In Diabetes Raises Blood Pressure 2Health News:Most Smokers Continue To Smoke Despite Developing Cancer 2
... 513 handheld pulse oximeters incorporate "digital ... able to process pulsatile signals at ... 100 times per second. This processing ... performance during motion or low perfusion, ...
CO 2 SMO-Capnograph/Pulse Oximeter...
... The Models 512 and 513 ... processing. This advanced technology is able ... higher resolutions and speeds of 100 ... results in improved pulse oximeter performance ...
The NPB-40 Handheld Pulse Oximeter is both compact and affordable. It is simple to operate, provides spot-check monitoring of SpO 2 and pulse rate, and is compact enough to fit in your pocket....
Medicine Products: